Dar es Salaam: The Nationwide Public Health Laboratory (NPHL) in Dar es Salaam has been formally designated as a World Health Organization (WHO) HIVResNet Nationwide Laboratory for HIV Drug Resistance (HIVDR) testing for 2025. This designation areas Tanzania on the forefront of world efforts to monitor and reply to HIV drug resistance, a severe component in the battle to extinguish the AIDS epidemic.
The designation follows NPHL’s a hit demonstration of technical proficiency in genotyping HIV-1 protease, reverse transcriptase, and integrase genes from plasma specimens the assure of the ThermoFisher industrial equipment. This success confirms the laboratory’s ability to generate top quality, upright data in line with worldwide standards diagram by WHO’s HIV Drug Resistance Network (HIVResNet).
“This recognition is a predominant milestone for Tanzania and a testomony to the commitment and technical excellence of our laboratory mavens,” Dr. Jean de Dieu Iragena, “It reaffirms our nationwide management in HIV surveillance and strengthens our contribution to world public health.”
The WHO HIVResNet designation helps a world strategy for HIVDR surveillance, developed to construct obvious antiretroviral therapy stays effective and sustainable in the face of rising drug resistance. NPHL’s inclusion in this network will play an fundamental role in producing robust, actionable data to train nationwide therapy insurance policies and optimize patient outcomes.
“We’re honored to regain this designation,” Dr. Nyambura Moremi. “It underscores the tireless work of our team and enhances our capability to toughen proof-based decisions in HIV care and therapy in Tanzania. Here’s not loyal a regain for us, however for the hundreds of lives we support.”
As a chosen HIVResNet laboratory, NPHL will proceed to take half in WHO’s annual proficiency testing and must set aside its high standards to stay in the network in future years. WHO has emphasized the importance of notifying the organization of any critical changes to the lab’s infrastructure or management, making sure sustained excellence.
“The designation of NPHL is a robust endorsement of the laboratory’s capability and commitment to public health,” acknowledged, Dr Charles Sagoe-Moses, Nation Guide of WHO “We commend Tanzania’s efforts to integrate quality HIVDR surveillance into its nationwide health strategy and seek ahead to continued collaboration.”
This fashion represents one other courageous step in Tanzania’s commitment to ending AIDS as a public health chance by 2030, and in making sure that no one is left on the abet of in the entry to stable, effective, and sustainable HIV therapy
